Efficacy and safety of combination of magnesium sulfate, phentolamine and nifedipine in treatment of patients with 
hypertensive disorder complicating pregnancy

Zhang,Jinggui; Li,Jun

doi:10.3892/etm.2019.7965

Efficacy and safety of combination of magnesium sulfate, phentolamine and nifedipine in treatment of patients with hypertensive disorder complicating pregnancy

Authors:
- Jinggui Zhang
- Jun Li
View Affiliations

Affiliations: Department of Cardiovascular Medicine, Affiliated Hospital of Beihua University, Jilin 132001, P.R. China, Screening Laboratory, Jilin Hospital for Gynecology and Obstetrics, Jilin 132011, P.R. China
Published online on: August 30, 2019 https://doi.org/10.3892/etm.2019.7965
Pages: 3341-3346
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Efficacy and safety of the combination of magnesium sulfate, phentolamine and nifedipine in the treatment of patients with hypertensive disorder complicating pregnancy (HDCP) and its effect on hemodynamics and urinary protein level were investigated. One hundred and six patients with HDCP diagnosed at the Affiliated Hospital of Beihua University from February 5, 2016 to May 9, 2017 were retrospectively analyzed. Patients were divided into the magnesium sulfate group and the combination group, according to the therapeutic schemes. The efficacy 1 week later was observed. The general clinical data of the patients were recorded, and data were acquired with respect to hemodynamic indexes before and after treatment [changes of S/D ratio of umbilical artery flow, and cardiac index and total peripheral resistance (TPR)], the 24‑h urinary protein level, clinical efficacy and safety [adverse drug reactions (ADR) and maternal and neonatal outcomes]. Before treatment, there was no statistically significant difference between the two groups in terms of S/D ratio of umbilical artery flow (P>0.05), while after treatment the S/D ratio was significantly lower than that before treatment in both groups (P<0.05). Before treatment, there was no statistically significant difference between the two groups in terms of cardiac index (P>0.05). TPR after treatment was significantly lower than that before treatment in both groups (P<0.001). Compared with the magnesium sulfate group, patients in the combination group had significantly lower 24‑h urinary protein level after treatment (P<0.001), significantly higher total effective rate (P<0.05), significantly lower incidence rate of ADR (P<0.001), and significantly lower incidence rate of adverse maternal and neonatal outcomes (P<0.001). In conclusion, the combination of magnesium sulfate, phentolamine and nifedipine can significantly improve the hemodynamic indexes, the 24‑h urinary protein level, the clinical efficacy, ADR and maternal and neonatal outcomes of patients with HDCP, therefore it is worthy of use in the clinic.

View Figures

View References

1	Barakat R, Pelaez M, Cordero Y, Perales M, Lopez C, Coteron J and Mottola MF; Randomized Clinical Trial, : Exercise during pregnancy protects against hypertension and macrosomia: Randomized clinical trial. Am J Obstet Gynecol. 214:649.e1–649.e8. 2016. View Article : Google Scholar
2	Liu FM, Zhao M, Wang M, Yang HL and Li L: Effect of regular oral intake of aspirin during pregnancy on pregnancy outcome of high-risk pregnancy-induced hypertension syndrome patients. Eur Rev Med Pharmacol Sci. 20:5013–5016. 2016.PubMed/NCBI
3	Madsen C, Håberg SE, Aamodt G, Stigum H, Magnus P, London SJ, Nystad W and Nafstad P: Preeclampsia and hypertension during pregnancy in areas with relatively low levels of traffic air pollution. Matern Child Health J. 22:512–519. 2018. View Article : Google Scholar : PubMed/NCBI
4	Johnson P, Montgomery M and Ewell P: Elevated blood pressure in low-income, rural preschool children is associated with maternal hypertension during pregnancy. J Community Health Nurs. 35:12–18. 2018. View Article : Google Scholar : PubMed/NCBI
5	Maged AM, Hashem AM, Gad Allah SH, Mahy ME, Mostafa WA and Kotb A: The effect of loading dose of magnesium sulfate on uterine, umbilical, and fetal middle cerebral arteries Doppler in women with severe preeclampsia: A case control study. Hypertens Pregnancy. 35:91–99. 2016. View Article : Google Scholar : PubMed/NCBI
6	Niwa K: Adult congenital heart disease with pregnancy. Korean Circ J. 48:251–276. 2018. View Article : Google Scholar : PubMed/NCBI
7	Brookfield KF, Su F, Elkomy MH, Drover DR, Lyell DJ and Carvalho B: Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol. 214:737.e1–737.e9. 2016. View Article : Google Scholar
8	Cho CK, Sung TY, Choi SJ, Choi HR, Kim YB, Lee JU and Yang HS: The effect of magnesium sulfate concentration on the effective concentration of rocuronium, and sugammadex-mediated reversal, in isolated left phrenic nerve hemi-diaphragm preparations from the rat. Korean J Anesthesiol. 71:401–406. 2018. View Article : Google Scholar : PubMed/NCBI
9	Sarma AK, Khandker N, Kurczewski L and Brophy GM: Medical management of epileptic seizures: Challenges and solutions. Neuropsychiatr Dis Treat. 12:467–485. 2016.PubMed/NCBI
10	Park JB, Shin JH, Kim DS, Youn HJ, Park SW, Shim WJ, Park CG, Kim DW, Lee HY, Choi DJ, et al FOCUS Investigators, : Safety of the up-titration of nifedipine GITS and valsartan or low-dose combination in uncontrolled hypertension: The FOCUS Study. Clin Ther. 38:832–842. 2016. View Article : Google Scholar : PubMed/NCBI
11	Webster LM, Myers JE, Nelson-Piercy C, Harding K, Cruickshank JK, Watt-Coote I, Khalil A, Wiesender C, Seed PT and Chappell LC: Labetalol versus Nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: A randomized controlled trial. Hypertension. 70:915–922. 2017. View Article : Google Scholar : PubMed/NCBI
12	Jin J, Shen X, Tai Y, Li S, Liu M, Zhen C, Xuan X, Zhang X, Hu N, Zhang X, et al: Arterial relaxation is coupled to inhibition of mitochondrial fission in arterial smooth muscle cells: Comparison of vasorelaxant effects of verapamil and phentolamine. Acta Pharm Sin B. 7:319–325. 2017. View Article : Google Scholar : PubMed/NCBI
13	Yan Z, Shang Y, Li F, Xie F, Qian H, Zhang Y and Yue B: Therapeutic efficacy of phentolamine in the management of severe hand, foot and mouth disease combined with pulmonary edema. Exp Ther Med. 13:1403–1407. 2017. View Article : Google Scholar : PubMed/NCBI
14	Schausberger CE, Jacobs VR, Bogner G, Wolfrum-Ristau P and Fischer T: Hypertensive disorders of pregnancy - a life-long risk?! Geburtshilfe Frauenheilkd. 73:47–52. 2013. View Article : Google Scholar : PubMed/NCBI
15	Hromadnikova I, Kotlabova K, Ivankova K, Vedmetskaya Y and Krofta L: Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction. Int J Cardiol. 249:402–409. 2017. View Article : Google Scholar : PubMed/NCBI
16	Petrakos G, Andriopoulos P and Tsironi M: Pregnancy in women with thalassemia: Challenges and solutions. Int J Womens Health. 8:441–451. 2016. View Article : Google Scholar : PubMed/NCBI
17	Flo K, Blix ES, Husebekk A, Thommessen A, Uhre AT, Wilsgaard T, Vårtun Å and Acharya G: A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy. Acta Obstet Gynecol Scand. 95:225–232. 2016. View Article : Google Scholar : PubMed/NCBI
18	Guy GP, Ling HZ, Garcia P, Poon LC and Nicolaides KH: Maternal cardiac function at 35–37 weeks' gestation: Prediction of pre-eclampsia and gestational hypertension. Ultrasound Obstet Gynecol. 49:61–66. 2017. View Article : Google Scholar : PubMed/NCBI
19	Tiralongo GM, Lo Presti D, Pisani I, Gagliardi G, Scala RL, Novelli GP, Vasapollo B, Andreoli A and Valensise H: Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia. Pregnancy Hypertens. 5:193–197. 2015. View Article : Google Scholar : PubMed/NCBI
20	Adamo KB, Ferraro ZM and Brett KE: Can we modify the intrauterine environment to halt the intergenerational cycle of obesity? Int J Environ Res Public Health. 9:1263–1307. 2012. View Article : Google Scholar : PubMed/NCBI
21	Siegel AM, Tita AT, Machemehl H, Biggio JR and Harper LM: Evaluation of institute of medicine guidelines for gestational weight gain in women with chronic hypertension. AJP Rep. 7:e145–e150. 2017. View Article : Google Scholar : PubMed/NCBI
22	Demirci O, Kumru P, Arınkan A, Ardıç C, Arısoy R, Tozkır E, Tandoğan B, Ayvacı H and Tuğrul AS: Spot protein/creatinine ratio in preeclampsia as an alternative for 24-hour urine protein. Balkan Med J. 32:51–55. 2015. View Article : Google Scholar : PubMed/NCBI
23	Stepan H, Kuse-Föhl S, Klockenbusch W, Rath W, Schauf B, Walther T and Schlembach D: Diagnosis and treatment of hypertensive pregnancy disorders. Guideline of DGGG (S1-level, AWMF registry no. 015/018, December 2013). Geburtshilfe Frauenheilkd. 75:900–914. 2015. View Article : Google Scholar : PubMed/NCBI
24	Kongwattanakul K, Saksiriwuttho P, Chaiyarach S and Thepsuthammarat K: Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health. 10:371–377. 2018. View Article : Google Scholar : PubMed/NCBI
25	Asgharnia M, Mirblouk F, Kazemi S, Pourmarzi D, Mahdipour Keivani M and Dalil Heirati SF: Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study. Int J Reprod Biomed (Yazd). 15:583–588. 2017. View Article : Google Scholar : PubMed/NCBI